Cargando…
Multi-omic analysis of the cardiac cellulome defines a vascular contribution to cardiac diastolic dysfunction in obese female mice
Coronary microvascular dysfunction (CMD) is associated with cardiac dysfunction and predictive of cardiac mortality in obesity, especially in females. Clinical data further support that CMD associates with development of heart failure with preserved ejection fraction and that mineralocorticoid recep...
Autores principales: | Dona, Malathi S. I., Hsu, Ian, Meuth, Alex I., Brown, Scott M., Bailey, Chastidy A., Aragonez, Christian G., Russell, Jacob J., Krstevski, Crisdion, Aroor, Annayya R., Chandrasekar, Bysani, Martinez-Lemus, Luis A., DeMarco, Vincent G., Grisanti, Laurel A., Jaffe, Iris Z., Pinto, Alexander R., Bender, Shawn B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060343/ https://www.ncbi.nlm.nih.gov/pubmed/36988733 http://dx.doi.org/10.1007/s00395-023-00983-6 |
Ejemplares similares
-
Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness
por: Aroor, Annayya R., et al.
Publicado: (2021) -
Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes
por: Habibi, Javad, et al.
Publicado: (2017) -
The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat
por: Habibi, Javad, et al.
Publicado: (2019) -
Cardiac Insulin Resistance and MicroRNA Modulators
por: Pulakat, Lakshmi, et al.
Publicado: (2012) -
Mapping the cellular and molecular landscape of cardiac non-myocytes in murine diabetic cardiomyopathy
por: Cohen, Charles D., et al.
Publicado: (2023)